FUJI PHARMA CO., LTD.

Transcripts Fuji Pharma Co., Ltd.

Equities

4554

JP3816200004

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-27 EDT			5-day change	1st Jan Change
1,500 ^JPY	+1.56%		-1.19%	-13.74%

2023	Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump	MT
2023	Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fuji Pharma Co., Ltd. Provides Financial Guidance for the Fiscal Year Ending September 30, 2022	21-11-18	CI
Fuji Pharma Co., Ltd. Reports Consolidated Earnings Results for the Three Months Ended December 31, 2019; Provides Consolidated Earnings Guidance for the Six Months Ending March 31, 2020 and Fiscal Year Ending September 30, 2020; Provides Dividend Guidance for the Second Quarter Ending March 31, 2020 and Fiscal Year Ending September 30, 2020	20-02-05	CI
Fuji Pharma Co., Ltd. Announces Consolidated and Non-Consolidated Earnings Results for the Year Ended September 30, 2015; Provides Consolidated and Non-Consolidated Earnings Guidance for the Half and Fiscal Year 2016; Announces Year End Dividend for the Fiscal Year 2015, Payable on December 21, 2015; Provides Year End Dividend Guidance for the Fiscal Year 2016	15-11-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer